Pnc Financial Services Group, Inc. Avidity Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 411 shares of RNA stock, worth $12,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
411
Previous 85
383.53%
Holding current value
$12,194
Previous $3,000
500.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RNA
# of Institutions
252Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$316 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$274 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$256 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$241 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$209 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.55B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...